Brief Report THROMBOSIS AND HEMOSTASIS Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities
نویسندگان
چکیده
Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction caused by platelet-activating IgG antibodies that recognize multimolecular PF4/heparin complexes. Therapeutic plasma exchange (TPE) has been recommended as a way to remove HIT antibodies quickly, as might be required to permit administration of heparin for urgent cardiac surgery. However, HIT antibodies (IgG) are not as effectively removed by TPE as IgM. Using serial pre-/ post-TPE sera obtained from a patient with subacute HIT (ie, recent HITwith platelet count recovery but persistingHIT antibodies) who underwent repeated TPE pre-cardiac surgery, we compared antibody reactivity by the C-serotonin-release assay (SRA)—a functional (platelet activation) test for HIT antibodies—vs an IgG-specific antiPF4/heparin enzyme-immunoassay (EIA). We found that although a negative SRA could be achieved quickly post-TPE, corresponding EIA reactivities remained strongly positive. This observation proved to be a general feature of HIT antibody reactivity, because 15 other acute HIT sera showed rapid diminution of SRA reactivity upon serial dilutions, but with major reductions in EIA reactivity requiring much greater sample dilutions.
منابع مشابه
Evaluating heparin-induced thrombocytopenia: the old and the new.
Heparin-induced thrombocytopenia (HIT) is a rare but potentially serious complication of heparin use. Prompt diagnosis is crucial and requires the integration of clinical assessment and laboratory testing. Pretest clinical scoring systems (i.e., 4 Ts) have been established. Immunoassays can detect the presence of antibodies directed toward heparin-platelet factor 4 (H-PF4) complexes, but provid...
متن کاملClinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach.
Heparin-induced thrombocytopenia (HIT) is a clinicopathologic disorder that predisposes to thrombosis. Diagnosis rests on a compatible clinical picture and laboratory evidence of antiplatelet factor 4 (PF4)/heparin antibodies that activate platelets in a heparin-dependent manner. Rapid and accurate diagnosis is paramount to avoid the perils of misdiagnosis. Clinical evaluation may be guided by ...
متن کاملDemand on-demand testing for the diagnosis of heparin-induced thrombocytopenia.
In theory,most laboratory tests for immune heparin-induced thrombocytopenia (HIT) can beperformedwithin a fewhours of blood sample acquisition. But for the most common type of test performed – the platelet factor 4 (PF4)-dependent enzyme-linked immunosorbent assay (ELISA) – the blood samples are almost always tested in batches, at most once-daily (and often not on weekends), and so results are ...
متن کاملDemand on-demand testing for the diagnosis of heparin-induced thrombocytopenia
In theory,most laboratory tests for immune heparin-induced thrombocytopenia (HIT) can beperformedwithin a fewhours of blood sample acquisition. But for the most common type of test performed – the platelet factor 4 (PF4)-dependent enzyme-linked immunosorbent assay (ELISA) – the blood samples are almost always tested in batches, at most once-daily (and often not on weekends), and so results are ...
متن کاملThe laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
Heparin-induced thrombocytopenia (HIT) is a serious adverse effect of heparin exposure that can progress to severe thrombosis, amputation, or death. HIT is an immune response in which antibodies cause platelet activation, platelet aggregation, the generation of procoagulant platelet microparticles, and activation of leukocytes and endothelial cells. Early diagnosis based on a comprehensive inte...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014